Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:57:02.885Z.
Consensus retrieved: 2026-10-06T13:30:27.159Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:57:02.885Z.
Quote observation: 2026-10-06T15:54:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0dc40ddd6b0c815ea8fb06d6c0f10798674f4babd9a38c246e46e89e51900236
Forward PE Ratio (N/A) = Dated Quote Price ($1.43) / Consensus Forward EPS ($-1.56)
FORWARD PE RATIO
N/A
Lite Strategy, Inc.
Market Cap
$48.68M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Lite Strategy, Inc. (LITS) | $48.68M | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.27M | N/A |
| Apollomics, Inc. (APLM)vs › | $49.85M | N/A |
| Celularity Inc. (CELU)vs › | $49.93M | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.81M | N/A |
| Clene Inc. (CLNN)vs › | $51.09M | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.18M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.34M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.36M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-06-30
At the dated quote price of $1.43, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-06-30 | $-1.56 | $-1.56 – $-1.56 | 1 | n/m |
| 2028-06-30 | $-1.56 | $-1.56 – $-1.56 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
